Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL

Clinical trial NCT07014917 · RECRUITING

Trial details

NCT number: NCT07014917
Sponsor: Zulfa Omer
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma CLL Variant

Start date: 2025-12-05
Primary completion: 2028-06-05
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.